tumor microenvironment receptor inhibitor (crossignal therapeutics)

N/A

Report date: 2025/01/26 17:34:36
NME

Base Information

Drug Nametumor microenvironment receptor inhibitor (crossignal therapeutics)
Drug Alias NameTMER 3/4 (Crossignal Therapeutics Inc)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionT-cell receptor agonists
TargetsT-cell receptor
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCrossignal Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesCrossignal Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A